Engineering CRISPR/Cas13 System against RNA Viruses: From Diagnostics to Therapeutics

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• RNA viruses pose significant global health threats, necessitating advanced diagnostic and therapeutic strategies.
• Current methods like ELISA and RT-qPCR for RNA virus detection have limitations in speed and sensitivity.
• Existing vaccines and antiviral drugs require lengthy development cycles.

Purpose of the Study:

• To review the emerging applications of the CRISPR-Cas13 system in combating RNA viruses.
• To highlight CRISPR-Cas13's potential in both RNA virus diagnostics and therapeutics.
• To illustrate CRISPR-Cas13's utility using examples like SARS-CoV-2, dengue virus, and HIV-1.

Main Methods:

• Review of current scientific literature on CRISPR-Cas13 applications against RNA viruses.
• Analysis of CRISPR-Cas13's RNA-targeting capabilities.
• Case studies focusing on specific RNA viruses (SARS-CoV-2, dengue, HIV-1).

Main Results:

• CRISPR-Cas13 demonstrates accurate RNA-targeting, distinguishing it within the CRISPR family.
• The system shows potential for rapid and sensitive RNA virus detection.
• CRISPR-Cas13 is being explored for direct antiviral therapeutic applications.

Conclusions:

• The CRISPR-Cas13 system presents a powerful and versatile tool for addressing RNA virus challenges.
• Its application in diagnostics and therapeutics offers a faster alternative to traditional methods.
• CRISPR-Cas13 holds significant promise for future pandemic preparedness and control.